Blood-Based Biomarkers for Alzheimer Disease-Ready for Primary Care?

JAMA Neurol. 2024 Oct 1;81(10):1030-1031. doi: 10.1001/jamaneurol.2024.2801.

Authors

Lawren VandeVrede¹, Gil D Rabinovici^{1

2

3}

Affiliations

¹ Memory & Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
² Department of Radiology & Biomedical Imaging, University of California, San Francisco, San Francisco, California.
³ Associate Editor, JAMA Neurology.

PMID: 39068546
DOI: 10.1001/jamaneurol.2024.2801

No abstract available

MeSH terms

Alzheimer Disease* / blood
Alzheimer Disease* / diagnosis
Biomarkers* / blood
Humans
Primary Health Care*

Substances

Biomarkers